One-year, randomized, open-label study comparing the safety and efficacy of lanthanum carbonate (Fosrenol®) and calcium carbonate in dialysis patients.

被引：0
|
作者：
Torres, A
De Broe, ME
D'Haese, PC
Hutchison, A
Jones, C
机构：
[1] Univ Canaries Hosp, Dept Nephrol, Tenerife, Spain
[2] Univ Antwerp, Dept Nephrol, B-2020 Antwerp, Belgium
[3] Manchester Royal Infirm, Inst Nephrol & Transplantat, Manchester M13 9WL, Lancs, England
[4] Shire Pharmaceut Grp Plc, Basingstoke, Hants, England
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：764A / 764A
页数：1
相关论文
共 50 条
  • [31] Open-label prospective study of efficacy and safety of levetiracetam:: One year follow-up
    Villanueva, VE
    Gutiérrez-Delicado, E
    Caicoya, AG
    Serratosa, JM
    EPILEPSIA, 2005, 46 : 270 - 270
  • [32] SEVELAMER CARBONATE VS. LANTHANUM CARBONATE VS. CALCIUM ACETATE/MAGNESIUM CARBONATE IN CKD PATIENTS ON HEMODIALYSIS: A RANDOMIZED STUDY
    Ekart, Robert
    Bevc, Sebastjan
    Dvorsak, Benjamin
    Hojs, Nina
    Hren, Martin
    Jakopin, Eva
    Knehtl, Masa
    Galuf, Tina Stropnik
    Hojs, Radovan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [33] Efficacy and Safety of Calcium Acetate-Magnesium Carbonate in the Treatment of Hyperphosphatemia in Dialysis Patients
    Helal, Imed
    Elkateb, Hanene
    Hedri, Hafedh
    Hajri, Malika
    Ben Hamida, Fethi
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2016, 27 (06) : 1162 - 1167
  • [34] AN OPEN-LABEL, SINGLE CENTER STUDY ASSESSING THE EFFICACY OF AMORPHOUS CALCIUM CARBONATE (ACC) SUPPLEMENT IN THE MANAGEMENT OF PRIMARY HYPOPARATHYROIDISM
    Segal, E.
    Ish-Shalom, S.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S250 - S250
  • [35] One-Year Safety and Efficacy of Mitapivat in Sickle Cell Disease: Follow-up Results of a Phase 2, Open-Label Study
    van Dijk, Panelmyrthe J.
    Rab, Minke A. E.
    van Oirschot, Brigitte A.
    Bos, Jennifer
    Derichs, Cleo
    Rijneveld, Anita W.
    Cnossen, Marjon H.
    Nur, Erfan
    Biemond, Bart J.
    Bartels, Marije
    Jans, Judith J. M.
    van Solinge, Wouter W.
    Schutgens, Roger E. G.
    van Wijk, Richard
    van Beers, Eduard J.
    BLOOD, 2023, 142
  • [36] One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study
    van Dijk, Myrthe J.
    Rab, Minke A. E.
    van Oirschot, Brigitte A.
    Bos, Jennifer
    Derichs, Cleo
    Rijneveld, Anita W.
    Cnossen, Marjon H.
    Nur, Erfan
    Biemond, Bart J.
    Bartels, Marije
    Jans, Judith J. M.
    van Solinge, Wouter W.
    Schutgens, Roger E. G.
    van Wijk, Richard
    van Beers, Eduard J.
    BLOOD ADVANCES, 2023, 7 (24) : 7539 - 7550
  • [37] An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema
    Sivaprasad, Sobha
    Browning, Richard C.
    Starita, Carla
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 1565 - 1571
  • [38] LONG-TERM SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PALIPERIDONE PALMITATE: A ONE-YEAR OPEN-LABEL STUDY IN PATIENTS WITH SCHIZOPHRENIA.
    Coppola, D.
    Liu, Y.
    Gopal, S.
    Remmerie, B.
    Samtani, M.
    Pandina, G.
    Hough, D.
    Nuamah, I.
    Sulaiman, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S25 - S25
  • [39] Long-term effectiveness and safety of blonanserin in patients with first-episode schizophrenia: A one-year open-label study
    Tenjin, T.
    Miyamoto, S.
    Ninomiya, Y.
    Miyake, N.
    Ogino, S.
    Harada, H.
    Yamashita, Y.
    Kaneda, Y.
    Sumiyoshi, T.
    Yamaguchi, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 110 - 110
  • [40] Efficacy and safety of calcium dobesilate in patients with chronic venous insufficiency: An open-label, multicenter study
    Angehrn, F
    INTERNATIONAL CONGRESS OF PHLEBOLOGY, 1996, : 93 - 97
12345